A phase II study on periarticular injection of Anti-cytokine therapy Magnetic for the treatment of osteoarthritic knee pain.

A phase II study on periarticular injection of Anti-cytokine therapy Magnetic for the treatment of osteoarthritic knee pain. - Anti-Cytokine therapy for knee pain (ACTKP)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015666

Enrollment

Registered

2014-11-11

Start date

2014-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with knee pain due to osteoarthritis

Interventions

knee injection of anti-TNFalfa inhibitors knee injection of IL6 inhibitors knee injection of Hyaluronic acid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients have a knee joint pain and the cause of pain could be explained pain in X-ray or MRI

Exclusion criteria

Exclusion criteria: 1 Patients with impaired consciousness 2 Patients with severe heart failure, renal failure, liver failure, and systemic complications such as respiratory failure

Design outcomes

Primary

Measure	Time frame
Pain relief	—

Countries

Japan

Contacts

Public ContactSeiji Ohtori

Graduate School of Medicine, Chiba University Orthopaedic Surgery

sohotri@faculty.chiba-u.jp043-226-2117

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026